Complete Market Access

Complete Market Access was founded in 1999 in response to the creation of NICE and the advent of Health Technology Assessments and has supported many of its clients in gaining reimbursement for their brands.

Our specific areas of expertise are:

Contributing to all sections of dossiers for submission to Health Technology Assessment (HTA) bodies and preparing responses to HTA body consultation documents (National Institute for Health and Clinical Excellence (NICE), both single and multiple technology appraisal processes, Scottish Medicines Consortium (SMC) and All Wales Medicines Strategy Group (AWMSG)

Developing product value strategy, communications and contributing to product value dossiers

Writing publications to support product value to payers

Completing evidence assessments of client or competitor products

Conducting systematic reviews and meta-analysis

Health economic modelling

Generating budget impact calculations and interactive models

Our expert team of consultants, medical writers, systematic reviewers, statisticians and project managers at Complete Market Access are dedicated to delivering high-quality, credible strategic market access insight, evidence based value demonstration and communications, throughout the brand lifecycle.